S
CDTX

SignatureFD’s Cidara Therapeutics CDTX Stock Holding History

SignatureFD’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26
Closed -$5.74K – 3496
2025
Q4 		$5.74K Buy
+26
New +$4.2K ﹤0.01% 2640

SignatureFD's CDTX Position: Q1 2026 in Review

SignatureFD sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 26 shares — an estimated $5.74K sold.

SignatureFD first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $5.74K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • SignatureFD reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 26 Cidara Therapeutics shares in Q1 2026, an estimated $5.74K.
  • SignatureFD first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
  • SignatureFD's Cidara Therapeutics position peaked at $5.74K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.